Débora B. Trentini Schmidt

Center for Molecular Medicine Cologne (CMMC)

Dr. Débora B. Trentini Schmidt CECAD Cologne
Dr. Débora B. Trentini Schmidt

Principal Investigator

Research Areas

2
3

Protein Quality Control and Stress Response

Our research group is interested in understanding how the ribosome is used as a platform for protein quality control and stress signaling.

Research Focus

Sustaining proteome balance is a challenging task in the face of many external and endogenous stresses that accumulate during ageing. This task is carried out by a large number of intricate cellular pathways promoting correct protein folding and the elimination of defective protein species. Most protein quality control systems act post-translationally, thereby allowing new proteins to engage with the protein folding machinery prior to decisions about degradation. A notable exception is the ribosome-associated quality control (RQC) pathway, which functions in removing partially synthesized protein products from ribosomes that have stalled during translation. In recent years, it became evident that the stalled ribosome serves as a signal for multiple processes, including protein quality control, mRNA silencing and degradation, and stress signaling. Our aim is to elucidate what the physiologically relevant causes of ribosome stalling are, and how RQC failure is connected to loss of proteome homeostasis and neurodegeneration.

Our aim is to elucidate the physiologically relevant causes of ribosome stalling, and how RQC failure is connected to loss of proteome homeostasis and neurodegeneration.

Our Goals

  • Our main objective is to elucidate specificity mechanisms of protein quality control. We want to characterize the division of labor between different protein quality control pathways by identifying the endogenous substrates of key proteostasis players, such as E3 ubiquitin ligases. The goal is to use this information to predict and experimentally test the determinants of substrate selection. In addition, we want to characterize the cellular consequences upon the ablation of specific proteostasis factors, and to analyze their regulation upon proteotoxic stress. The long-term vision is to contribute to the understanding of the pathological states established upon age-dependent decline in proteostasis capacity and to pinpoint potential targets of therapy.
  • Prior to establishing her group, Dr. Trentini identified the physiological substrates of the ribosome-associated quality control (RQC) pathway in human cells. This pathway is recruited to ribosomes that stalled during translation and serves to target the nascent polypeptides produced by these failed translation events for degradation. Our study showed that RQC-mediated degradation is independent of the folding state of the stalled substrates, which distinguishes RQC from canonical quality control pathways that rely on structural cues for targeting. In addition, we identified gene/protein traits associated with increased risk of RQC-mediated degradation, such as: long sequences, tendency towards premature polyadenylation, and large numbers of transmembrane domains.
  • We have previously characterized the endogenous targets of RQC-mediated degradation in human cells using advanced mass spectrometry analysis. We discovered that large multipass transmembrane proteins are particularly susceptible to RQC-mediated degradation, suggesting that problems in co-translational membrane insertion could represent a trigger for ribosome stalling. We are currently investigating the causes of ribosome stalling and RQC recruitment during the synthesis of complex transmembrane proteins at the ER. Since mutated transmembrane proteins are the cause of prominent genetic disorders, we will also study the impact of disease-associated mutations on co-translational quality control processes, thereby exploring new potential venues for therapy.

Key Publications


  1. Eisenack TJ, and Trentini DB (2023). Ending a bad start: Triggers and mechanisms of co-translational protein degradation. Front Mol Biosci.  https://doi.org/10.3389/fmolb.2022.1089825
     
  2. Trentini DB, Pecoraro M, Tiwary S, Cox J, Mann M, Hipp MS, and Hartl FU (2020) Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation. Proc Natl Acad Sci U S A., 117(8): 4099-4108­­ https://doi.org/10.1073/pnas.1914401117
Dr. Débora B. Trentini Schmidt CECAD Cologne
Dr. Débora B. Trentini Schmidt

Principal Investigator

Research Areas

2
3